melatonin has been researched along with Androgen-Independent Prostatic Cancer in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Melatonin (MLT) is a functionally pleiotropic indoleamine molecule and a key regulator of energy metabolism." | 1.62 | Melatonin inhibits lipid accumulation to repress prostate cancer progression by mediating the epigenetic modification of CES1. ( Chen, K; Chen, Z; Hou, Y; Hu, J; Liu, L; Sugimura, H; Tao, H; Wang, L; Yang, X; Zhang, C; Zhou, L, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhou, L | 1 |
| Zhang, C | 1 |
| Yang, X | 1 |
| Liu, L | 1 |
| Hu, J | 1 |
| Hou, Y | 1 |
| Tao, H | 1 |
| Sugimura, H | 1 |
| Chen, Z | 1 |
| Wang, L | 1 |
| Chen, K | 1 |
1 other study available for melatonin and Androgen-Independent Prostatic Cancer
| Article | Year |
|---|---|
Melatonin inhibits lipid accumulation to repress prostate cancer progression by mediating the epigenetic modification of CES1.
Topics: Acetylation; Androgen Antagonists; Animals; Antioxidants; Apoptosis; Benzamides; Biomarkers, Tumor; | 2021 |